Standard vs. point-of-care measurement of fibrinogen: Potential impact on clinical decisions

Minerva Anestesiologica

Volumn 78, Issue 5, 2012, Pages 550-555

  Urwyler, N ^a,b   Theiler, L ^a,c   Hirschberg, M ^a   Kleine Brueggeney, M ^a,d   Colucci, G ^a   Greif, R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Anesthesiology; Blood component transfusion; Blood transfusion; Fibrinogen; Intraoperative care

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD COMPONENT THERAPY; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PEROPERATIVE CARE; PILOT STUDY; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ADULT; AGED; BLOOD COAGULATION TESTS; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PILOT PROJECTS; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES;

EID: 84860299782     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208.
2. Kozek-Langenecker S: Management of massive operative blood loss. Minerva Anestesiol 2007;73:401-415.
3. Caraceni A, Cavaliere F, Galante D, Landoni G. A year in Review in Minerva Anestesiologica, 2009. Minerva Anestesiol 2010;76:158-168.
4. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009;113:3406-3417.
5. Triulzi DJ. Transfusion-related acute lung injury:current concepts for the clinician. Anesth Analg 2009;108:770-776.
6. Chiumello D, Caironi P, Grasso S, Mascia L, Terragni PP, Rossi M. A year in review in Minerva Anestesiologica 2010. Critical care. Experimental and clinical studies. Minerva Anestesiol 2011;77:101-115.
7. Haas T, Fries D, Velik-Salchner C, Oswald E, Innerhofer P. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008;106:725-731.
8. Jeger V, Urwyler N, Zimmermann H, Exadaktylos AK. Trauma-induced coagulopathy in severely injured patients: knowledge lost in translation? Emerg Med J 2010;27:551-552.
9. Urwyler N, Staub LP, Beran D, Deplazes M, Lord SJ, Alberio L et al. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test? Thromb Haemost 2009;102:779-786.
10. Chiumello D, Cavaliere F, De Cosmo G, Galante D, Pietrini D. A year in review in Minerva Anestesiologica, 2010. Minerva Anestesiol 2011;77:243-256.
11. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery:the role of fibrinogen administration. Anesth Analg 2007;105:905-917.
12. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy:a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009;7:795-802.
13. Schochl H, Forster L, Woidke R, Solomon C, Voelckel W. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010;65:199-203.
14. Bischof D, Dalbert S, Zollinger A, Ganter MT, Hofer CK. Thrombelastography in the surgical patient. Minerva Anestesiol 2010;76:131-137.
15. Cushing M, Shaz BH. Blood transfusion in trauma patients:unresolved questions. Minerva Anestesiol 2011;77: 349-359.
16. Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009;138:694-702.
17. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level:a pilot study. Br J Anaesth 2009;102:785-792.
18. Rahe-Meyer N, Sorensen B. For: Fibrinogen concentrate for management of bleeding. J Thromb Haemost 2011;9:1-5.
19. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S et al. Guidelines for the use of freshfrozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126:11-28.
20. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez- Mondejar E, Gordini G et al. Management of bleeding following major trauma: a European guideline. Crit Care 2007;11:R17.
21. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957;17:237-246.
22. Colucci G, Giabbani E, Barizzi G, Urwyler N, Alberio L. Laboratory-based ROTEM analysis:implementing pneumatic tube transport and real-time graphic transmission. Int J Lab Hematol 2011;33:441-446.
23. Olorundare OE, Simmons SR, Albrecht RM. Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets:a correlative light and electron microscopic investigation. Blood 1992;79:99-109.
24. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-310.
25. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009;102:793-799.
26. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E et al. Management of bleeding following major trauma:an updated European guideline. Crit Care 2010;14:R52.
27. Ozier Y, Hunt BJ. Against: fibrinogen concentrate for management of bleeding:against indiscriminate use. J Thromb Haemost 2011;9:6-8.
28. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sorensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010;50:2571-2576.
29. Adam S, Karger R, Kretschmer V. Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. Clin Appl Thromb Hemost 2010;16:454-460.
30. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009;17:45.
31. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011:CD007871.